Publication details for Dr Gary SharplesPan, P.-S., Curtis, F.A., Carroll, C.L., Medina, I., Rodrigeuz, R., Liotta, L.A., Sharples, G.J. & McAlpine, S.R. (2006). Novel antibiotics: C-2 symmetrical macrocycles inhibiting Holliday junction DNA binding by E. coli RuvC. Bioorganic & Medicinal Chemistry 14(14): 4731-4739.
- Publication type: Journal Article
- ISSN/ISBN: 0968-0896
- DOI: 10.1016/j.bmc.2006.03.028
- Keywords: Cyclicpeptides; Macrocycles; Antibiotics; Holliday junction; Antibiotic resistance; Peptides
- Further publication details on publisher web site
- View in another repository - may include full text
Author(s) from Durham
Holliday junctions (HJs) are formed as transient DNA intermediates during site-specific and homologous recombination. Both of these genetic exchange pathways are critical for normal DNA metabolism and repair. Trapping HJs leads to bacterial cell death by preventing proper segregation of the resulting interlinked chromosomes. Macrocyclic peptides designed to target this intermediate were synthesized with the goal of identifying compounds with specificity for this unique molecular target. We discovered ten macrocycles, both hexameric and octameric peptides, capable of trapping HJs in vitro. Those macrocycles containing tyrosine residues proved most effective. These data demonstrate that C-2 symmetrical macrocycles offer excellent synthetic targets for the development of novel antibiotic agents. Furthermore, the active compounds identified provide valuable tools for probing different pathways of recombinational exchange.